European Stocks Extend First-Half Rally as Cyclicals Advance
European stocks extended gains on Monday, led by cyclical sectors, as signs of cooling US inflation fueled appetite
2023-07-03 15:51
New AstraZeneca Cancer Drug Shows Potential in Key Study
An AstraZeneca Plc cancer medicine showed a statistically significant improvement over standard chemotherapy in a high-level study. The
2023-07-03 14:46
Eli Lilly’s Experimental Weight-Loss Shot Gives Company’s Strongest Results Yet
An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments
2023-06-27 05:18
Sanofi Cuts Zantac Exposure With Arbitration Win Over Boehringer
Sanofi defeated Boehringer Ingelheim GmbH in an arbitration proceeding over legal responsibilities tied to controversial heartburn medicine Zantac.
2023-06-20 14:48
Only Labour Can Fix the NHS, Says Boris Johnson’s Vaccine Czar
The National Health Service is “hopeless” and needs a “complete restructuring,” says the woman behind one of its
2023-06-15 12:27
Pan-African Approach Needed to Ensure Food Security: New Economy
A pan-African approach is needed to solve the continent’s food-security dilemma given the high cost of developing agricultural
2023-06-14 23:22
Britain’s Post-Brexit Policy Drift Alarms World’s Executives
When Dan Vahdat set out to build a healthcare startup, the UK was an ideal launchpad. That was
2023-06-12 07:18
Astra Enters Into $2 Billion-Plus Pact With UK Biotech Quell
AstraZeneca Plc entered a collaboration with UK biotech Quell Therapeutics potentially worth more than $2 billion to develop
2023-06-09 15:24
AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs
When Japanese pharmaceutical company Daiichi Sankyo Co. discovered a groundbreaking cancer treatment, it turned to bigger Western drugmaker
2023-06-07 05:28
Your Sunday US Briefing: Shangri-la Handshake, Big Rate Decisions
Hello from New York, where we’re looking to fill the hole left by last week’s Succession finale. Back
2023-06-04 23:20
Astra Drops Bowel Disease Drug Program After Delays
AstraZeneca Plc abandoned the development of a medicine in advanced tests called brazikumab for inflammatory bowel diseases like
2023-06-01 14:57
Catalent Cuts Annual Forecast More Than Expected, Delays Earnings Report Again
Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal
2023-05-19 22:20